Award recordCONTRACT

SOFIE CO.

PIID 36C25620C0010· VHA· 256-NETWORK CONTRACT OFFICE 16 (36C256)· 6505 · DRUGS AND BIOLOGICALS· FY2020· $488,394 net obligations· UEI JV1AHJHGUGG3· VA

Description

FINAL INVOICES ADDED LATE FUNDING TO PAY FOR THOSE.

Base award description: RADIOPHARMACEUTICALS

First action · last action
2019-10-01 · 2025-06-11
Transactions
14
First transaction's obligation
$129,000
Base + all options value (sum of deltas)
$1,828,575
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
4
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 14 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$596,367$0Base award · 2019-10-01 · this action $129,000 · running total $129,000Modification P00001 · 2020-09-09 · this action $0 · running total $129,000Modification P00002 · 2020-10-01 · this action $129,000 · running total $258,000Modification P00003 · 2021-02-01 · this action -$7,740 · running total $250,260Modification P00004 · 2021-10-01 · this action $129,000 · running total $379,260Modification P00006 · 2022-03-31 · this action -$16,512 · running total $362,748Modification P00007 · 2022-10-01 · this action $129,000 · running total $491,748Modification P00008 · 2023-03-08 · this action -$24,381 · running total $467,367Modification P00010 · 2023-09-19 · this action $0 · running total $467,367Modification P00011 · 2023-10-01 · this action $129,000 · running total $596,367Modification P00012 · 2024-02-09 · this action -$61,017 · running total $535,350Modification P00013 · 2024-08-29 · this action $0 · running total $535,350Modification P00014 · 2025-04-25 · this action -$50,181 · running total $485,169Modification P00015 · 2025-06-11 · this action $3,225 · running total $488,394
  • Base2019-10-01+$129,000= $129,000
  • Mod P000012020-09-09+$0= $129,000
  • Mod P000022020-10-01+$129,000= $258,000
  • Mod P000032021-02-01-$7,740= $250,260
  • Mod P000042021-10-01+$129,000= $379,260
  • Mod P000062022-03-31-$16,512= $362,748
  • Mod P000072022-10-01+$129,000= $491,748
  • Mod P000082023-03-08-$24,381= $467,367
  • Mod P000102023-09-19+$0= $467,367
  • Mod P000112023-10-01+$129,000= $596,367
  • Mod P000122024-02-09-$61,017= $535,350
  • Mod P000132024-08-29+$0= $535,350
  • Mod P000142025-04-25-$50,181= $485,169
  • Mod P000152025-06-11+$3,225= $488,394
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2019-10-01+$129,000$129,000RADIOPHARMACEUTICALS
Mod P00001· EXERCISE AN OPTION2020-09-09+$0$129,000RADIOPHARMACEUTICALS EXERCISE OPTION YEAR ONE
Mod P00002· FUNDING ONLY ACTION2020-10-01+$129,000$258,000RADIOPHARMACEUTICALS - FUND OPTION YEAR 1
Mod P00003· FUNDING ONLY ACTION2021-02-01−$7,740$250,260RADIOPHARMACEUTICALS - FUND OPTION YEAR 1
Mod P00004· EXERCISE AN OPTION2021-10-01+$129,000$379,260RADIOPHARMACEUTICALS - FUND OPTION YEAR 2
Mod P00006· FUNDING ONLY ACTION2022-03-31−$16,512$362,748RADIOPHARMACEUTICALS - DEOBLIGATION OF EXCESS FY19 FUNDS
Mod P00007· EXERCISE AN OPTION2022-10-01+$129,000$491,748RADIOPHARMACEUTICALS - DEOBLIGATION OF EXCESS FY19 FUNDS
Mod P00008· FUNDING ONLY ACTION2023-03-08−$24,381$467,367RADIOPHARMACEUTICALS - DEOBLIGATION OF EXCESS FY19 FUNDS
Mod P00010· EXERCISE AN OPTION2023-09-19+$0$467,367RADIOPHARMACEUTICALS - EXERCISING OPT 1 NO-COST MOD
Mod P00011· FUNDING ONLY ACTION2023-10-01+$129,000$596,367RADIOPHARMACEUTICALS - EXERCISING OPT 1 NO-COST MOD
Mod P00012· FUNDING ONLY ACTION2024-02-09−$61,017$535,350RADIOPHARMACEUTICALS
Mod P00013· OTHER ADMINISTRATIVE ACTION2024-08-29+$0$535,350RADIOPHARMACEUTICALS
Mod P00014· FUNDING ONLY ACTION2025-04-25−$50,181$485,169RADIOPHARMACEUTICALS - MODIFICATION TO EXTEND THE END DATE. DEOB FOR EXCESS FUNDS NOT USED.
Mod P00015· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2025-06-11+$3,225$488,394FINAL INVOICES ADDED LATE FUNDING TO PAY FOR THOSE.

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI JV1AHJHGUGG3)

AwardOffice · PSC / listingNet obligationsFY
36C25526N0392255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS$357,066FY2026
36C25526N0245255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS$1,172,834FY2026
36C24226N0463242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS$624,017FY2026
36C24226N0388242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS$830,796FY2026
36C24226D0040242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS$0FY2026
36C25026P0310250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS$347,000FY2026

Other recipients under 6505 from 256-NETWORK CONTRACT OFFICE 16 (36C256) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C25626N0555CARDINAL HEALTH 414, LLC256-NETWORK CONTRACT OFFICE 16 (36C256)$654,692FY2026
36C25626P0618HANGER PROSTHETICS & ORTHOTICS INC256-NETWORK CONTRACT OFFICE 16 (36C256)$15,119FY2026
36C25626N0492BAYER HEALTHCARE PHARMACEUTICALS INC256-NETWORK CONTRACT OFFICE 16 (36C256)$386,860FY2026
36C25626N0469CARDINAL HEALTH 414, LLC256-NETWORK CONTRACT OFFICE 16 (36C256)$396,000FY2026
36C25626N0461CARDINAL HEALTH 414, LLC256-NETWORK CONTRACT OFFICE 16 (36C256)$271,226FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25620C0010_3600_-NONE-_-NONE- · retrieved 2026-09-26.